Calculating correct Down's syndrome risks

被引:25
作者
Cuckle, H [1 ]
Sehmi, I [1 ]
机构
[1] Univ Leeds, Ctr Reprod Growth & Dev, Res Sch Med, Leeds, W Yorkshire, England
来源
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1999年 / 106卷 / 04期
关键词
D O I
10.1111/j.1471-0528.1999.tb08277.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Women having both first trimester nuchal translucency and second trimester serum screening tests are likely to receive two different Down's syndrome risks. Neither will be correct, and we describe how to calculate a valid combined risk. This uses the reported serum-based risk and a likelihood ratio derived from the nuchal translucency report. Tables, figures and examples are provided to aid the calculation of the likelihood ratio from either the nuchal translucency in multiples of the normal median, the nuchal translucency and crown-rump length in millimetres, or the reported prior and nuchal translucency-based risks.
引用
收藏
页码:371 / 372
页数:2
相关论文
共 8 条
  • [1] Established markers in second trimester maternal serum
    Cuckle, H
    [J]. EARLY HUMAN DEVELOPMENT, 1996, 47 : S27 - S29
  • [2] Cuckle H, 1998, LANCET, V352, P1144, DOI 10.1016/S0140-6736(98)00030-0
  • [3] CUCKLE HS, IN PRESS PRENAT DIAG
  • [4] NICOLAIDES KH, 1998, PRENAT DIAGN, V14, P203
  • [5] First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency
    Orlandi, F
    Damiani, G
    Hallahan, TW
    Krantz, DA
    Macri, JN
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1997, 10 (06) : 381 - 386
  • [6] UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation
    Snijders, RJM
    Noble, P
    Sebire, N
    Souka, A
    Nicolaides, KH
    [J]. LANCET, 1998, 352 (9125) : 343 - 346
  • [7] Spencer K, 1997, PRENATAL DIAG, V17, P525, DOI 10.1002/(SICI)1097-0223(199706)17:6<525::AID-PD105>3.0.CO
  • [8] 2-I